- PR Newswire•yesterday
NASHVILLE, Tenn., April 26, 2017 /PRNewswire/ -- Cumberland Pharmaceuticals (CPIX), a U.S. specialty pharmaceutical company and Poly Pharmaceuticals Inc., a privately-held U.S. specialty pharmaceutical company, have entered into a co-promotion partnership for Kristalose® within the United States. Poly's sales force will more than double the number of nationwide physicians called upon in support of the product.
- PR Newswire•last month
NASHVILLE, Tenn., March 27, 2017 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (CPIX) today announced the publication of a trial providing evidence that using Caldolor in multimodal pain control strategies improves postoperative pain control and reduces opioid use in patients undergoing transsphenoidal surgery. The trial was conducted at the Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center in Phoenix, Arizona, and was published in the Journal of Neurosurgery, March 2017. "The United States is in the midst of an epidemic of excessive opioid use, misuse, and abuse to control chronic pain," said AJ Kazimi, Chief Executive Officer of Cumberland Pharmaceuticals.
- Accesswire•last month
INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Cumberland Pharmaceuticals Inc.
NEW YORK, NY / ACCESSWIRE / March 22, 2017 / Levi & Korsinsky announces it has commenced an investigation Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) concerning possible breaches of fiduciary duty. ...
CPIX : Summary for Cumberland Pharmaceuticals Inc. - Yahoo Finance
Cumberland Pharmaceuticals Inc. (CPIX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||6.02 x 100|
|Ask||6.08 x 100|
|Day's Range||5.87 - 6.10|
|52 Week Range||4.27 - 7.48|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-98.00|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|